Diagnostic approach to the evaluation of myeloid malignancies following CAR T-cell therapy in B-cell acute lymphoblastic leukemia
George Mo, Nirali N. Shah(National Institutes of Health), Brandon M. Triplett(St. Jude Children's Research Hospital), Xiaolin Wu(Jiamusi University), Terry J. Fry(University of Colorado Anschutz Medical Campus), Javed Khan(Kent State University), Aimee C. Talleur(St. Jude Children's Research Hospital), Bonnie Yates(National Institutes of Health), Katherine R. Calvo(National Institutes of Health Clinical Center), Shilpa Shahani(City of Hope), Haneen Shalabi(Center for Cancer Research), Young Song(University of British Columbia), Rebecca Gardner(Seattle Children's Hospital), Hao‐Wei Wang(Fu Jen Catholic University), Katharine Patrick(Sheffield Children's NHS Foundation Trust), Michael G. Douvas(University of Virginia), Sridhar Chaganti(Cutaneous Lymphoma Foundation), Jack F. Shern(National Institutes of Health)
Cited by 31
Related Papers
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
|Transplantation and Cellular Therapy|2018|3.6k
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data
|Blood|2022|2.8k
Classification and diagnostic prediction of cancers using gene expression profiling and artificial neural networks
|Nature Medicine|2001|2.7k
Axicabtagene Ciloleucel as Second-Line Therapy for Large B-Cell Lymphoma
|New England Journal of Medicine|2021|1.6k